Xinnate appoints Anna-Karin Lindqvist as new COO
We are delighted to welcome Anna-Karin Lindqvist to our team as our new COO.
With extensive experience in the pharmaceuticals industry, Anna-Karin has proven expertise in bringing pharmaceutical products from discovery through to market authorization approval and launch. Her arrival marks a significant milestone for our team as we prepare for the next phase of development. Please join us in welcoming Anna-Karin to our team!
